between the excretion of the 6-oxygenated metabolites and pregnanediol. The ratio of 6oxygenated metabolites to pregnanediol found up to the 34th week of pregnancy was similar to that found in menstruating women and in subjects injected with progesterone. From the amounts of "C-progesterone excreted as pregnanediol or as 6-oxygenated metabolites by women between the 9th and 14th weeks of pregnancy, the daily production of progesterone was estimated to be from 25 to 80 mg/day. There was good agreement between the values whether these were calculated from pregnanediol excretion or from the excretion of 6-oxygenated metabolites. The similarity of these values and the close correlation between the excretion of the 6-oxygenated metabolites and pregnanediol in the normally menstruating female when progesterone production was low, during early pregnancy when progesterone production was very much higher, and in women injected with progesterone, suggests that the 6-oxygenated metabolites are derived mainly by hydroxylation of progesterone in peripheral tissues and not from 6-hydroxy or 6-oxo progesterone secreted by endocrine tissues. From the 34th week of pregnancy onwards pregnanediol excretion remained almost constant, whereas the excretion of 6oxygenated metabolites continued to increase. The mean value for the daily excretion of pregnanediol changed from 39-2 mg at ten weeks before delivery to 42-6 mg during the week of delivery, and there was no significant difference between pregnanediol excretion at these two times. The mean value for the excretion of the 6oxygenated metabolites rose from 4 5 mg/day at ten weeks before delivery to 7-2 mg/day during the week of delivery, an increase of 60 %, and the difference between these two values was statistically significant.
Since we thought that this increase in production of 6-oxygenated metabolites might be a reflection of the activity of the foetus in hydroxylating progesterone, the values obtained for the excretion of pregnanediol and 6-oxygenated metabolites on urine specimens collected between the 36th and 39th weeks of pregnancy were compared with the foetal and placental weights. There were significant correlations between the excretion of 6-oxygenated metabolites and both fretal and placental weights, but no significant correlation between pregnanediol excretion and foetal and placental weights.
There is at present very little information regarding the relative importance of metabolites other than pregnanediol in the metabolism of progesterone. Our investigations of this problem were carried out between the 8th and 14th weeks of pregnancy in women who were scheduled for termination of pregnancy. The women were given an intravenous dose of 144C-progesterone, urine was collected for five days and hydrolysed and extracted according to conventional procedures. The extracts were then divided by chromatographic procedures into three distinct fractions.
Fraction 1 consisted predominantly of pregnanediol and contained 28 5% of the urinary radioactivity (9-2% of the administered dose of progesterone): this latter value is within the range found by other investigators for the conversion of progesterone to pregnanediol.
Fraction 2 consisted of metabolites which were chromatographically less polar than pregnanediol and contained 23 % of the urinary radioactivity (7'5 % of the administered dose). One quarter of this fraction consisted of pregnanolone (3ahydroxy-5,-pregnan-20-one) and its isomers, a further 12 % consisted of less polar isomers of pregnanediol and there was also evidence for the presence in this fraction of pregnane-3, 6,20trione and a number of unidentified metabolites.
Fraction 3 consisted of metabolites of the hydroxylated derivatives of progesterone which were chromatographically more polar than pregnanediol. This fraction contained 31 % of the extracted radioactivity (10.2% of the administered dose) and consisted mainly of 6-oxygenated metabolites and 16-hydroxylated metabolites.
The amount of 6-oxygenated metabolites in each of the three fractions was estimated by oxidizing each fraction with chromic acid so that the 6-oxygenated metabolites were converted to pregnane-3,6,20-trione and this steroid could then be estimated. By this procedure it was shown that 19% of the less polar fraction and 50 % of the polar fraction consisted of 6-oxygenated metabolites. Thus a minimum of 6 % of the administered dose of progesterone was metabolized to 6oxygenated steroids and just under 10 % to pregnanediol. These figures show that 6-hydroxylation of progesterone is an important metabolic pathway. The present paper describes a study of cestrogen and pregnanediol excretion in 55 patients with threatened abortion and 41 patients with suspected hydatidiform mole.
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Methods Urinary cestrogens were measured by the rapid methods described by Brown et al. (1968) . Control values were obtained from 206 cestrogen measurements performed on 85 patients between 3 and 15 weeks after the last normal menstrual period, and from 2,085 measurements performed on 597 women between 14 weeks and delivery (Beischer et at. 1969) . The criteria for inclusion in the control series were an accurate assessment of dates and the eventual delivery of a surviving infant.
Urinary pregnanediol was measured by gasliquid chromatography using the method of Cox (1963) . The control series comprised 1,080 measurements on 480 patients.
Human chorionic gonadotrophin (HCG) was measured on 24-hour collections of urine by the Gravindex latex agglutination inhibition technique. Doubling serial dilutions were used and the results were expressed as the logarithmic mean of the highest dilution giving a positive result and the lowest dilution giving a negative result in i.u. per 24-hour urine. The upper limit for normal single pregnancies obtained from over 5,000 determinations was 350,000 i.u. per 24 hours.
ThreatenedAbortion
The 55 patients were admitted to hospital because of vaginal bleeding before 28 weeks of gestation. Pregnancy was proven in all cases. Abortion eventually occurred in 33. Urine was collected as soon as possible after the bleeding episode and thereafter at intervals until abortion occurred or throughout the remainder of the pregnancy. In general, hormone therapy was not given.
The cestrogen and pregnanediol values obtained in the first 24-hour collection after admission are summarized in Figs 1 and 2. In 22 patients (40 Y.) oestrogen values were below the 1st percentile for the control series. All these aborted, 20 within a week of the measurement, and the other 2 were The pregnanediol values, which were obtained in 51 of the 55 patients, showed the same trends and in general provided confirmatory evidence to the aestrogen measurements. All the 20 patients with pregnanediol values below the 1st percentile aborted. Of these, 14 had values below 2 mg/24 h. Of the 31 pregnancies with values at or above the 1st percentile, 19 resulted in surviving infants and 12 ended in abortion. Serial cestrogen and pregnanediol measurements were performed in 19 patients who aborted and in 22 patients whose pregnancies continued. In the 10 patients with values initially below the 1st percentile, the trend was to still lower values and in none was a rising value recorded; all the final pregnanediol values were below 1 mg/24 h before abortion occurred. In the 31 patients with steroid levels initially at or above the 1st percentile, 7 of the 9 who aborted showed normal trends in steroid excretion although 5 had one or more values below the 10th percentile, and only two showed values which eventually fell below the 1st percentile. The values found in the 22 patients with continuing pregnancies were distributed as in the control series, although there was a significantly higher proportion (21 %) with pregnanediol values below the 10th percentile. There was therefore evidence that a threatening episode did predispose to placental insufficiency later.
Hydatidiform Mole
Of the 41 patients with suspected hydatidiform mole, the diagnosis was subsequently established in 17, of whom 4 had a foetus co-existent with the mole. Of the 24 non-molar pregnancies, 6 aborted between 9 and 27 weeks and the remainder continued. There were 3 multiple pregnancies, all natural, 2 were twin and aborted at 20 and 27 weeks, and one was quadruplet pregnancy which resulted in three surviving infants.
The values for cestrogen and HCG excretion, and for pregnanediol and HCG excretion obtained at the initial assessment, are shown in Figs  3 and 4 . The steroid values are expressed as percentiles ofthe control series.
All the 8 pregnancies associated with high HCG values (above 350,000 i.u./24 h) and with cestrogen values above the 1st percentile, were molar; this represented 47% of the molar pregnancies. Six pregnancies were associated with normal HCG excretion and cestrogen levels below the 1st percentile; 5 of these were molar, and in the other still-born macerated twins were aborted at 27 weeks. Normal levels of HCG and urinary cestrogens were found in 27 pregnancies; these included all the 18 continuing pregnancies, 4 of the abortions and 4 ofthe molar pregnancies, 2 of which had a co-existent fcetus. The quadruple and one of the twin pregnancies were associated with p0OQ000 0 . . higher than normal oestrogen values. While the finding of such high values in the presence of HCG figures near the upper limit of normal suggests a multiple pregnancy, it is not an absolute finding since one of the molar pregnancies was also associated with cestrogen values of this order. The pregnanediol values showed a similar picture and could therefore be used for confirming the (estrogen values. One of the molar pregnancies with both normal (estrogen and HCG values was associated with a pregnanediol value below 2 mg/24 h, showing that this pregnancy was abnormal. Thus, when considering the results of all three tests, a diagnosis of an abnormal pregnancy could be made in 14 of the 17 patients with hydatidiform mole (82 Y.). In 2 ofthe 3 exceptions, a living fetus was co-existent with the mole and normal values might have been expected in these.
Oo-
No pregnancies were encountered with HCG values above 350,000 i.u. and very low (estrogen and pregnanediol values. This contrasts with the findings of Frandsen & Stakemann (1964) , who reported that the majority of their molar pregnancies fell within this category. Measurements were continued after evacuation of the mole in 10 patients. The levels of HCG fell immediately and, except for 2 patients who were subsequently treated for choriocarcinoma, the 3.000,000 *k000.OO Section ofEndocrinology with Section ofObstetrics & Gynecology 1095 levels had fallen below 500 i.u./24 h within seven weeks of molar abortion. However, a similar immediate fall in cestrogen and pregnanediol excretion occurred in only 4 patients; in the other 6 the values remained elevated for periods of up to seven weeks before falling to nonpregnant levels. In one patient, the values actually increased for three weeks, at which time she required laparotomy because of hemorrhage into a lutein cyst. This delayed fall in steroid excretion tended to be most marked in the patients with the highest initial levels of steroid and HCG excretion. From these findings, it appears that urinary excretion of cestrogens up to approximately 300 ,ug/24 h and of pregnanediol up to 10 mg/24 h can be derived from the hydatidiform mole itself, and that values above this are most likely to be contributed by theca-lutein cysts in the ovaries.
The overall study demonstrated the value of routine estrogen and pregnanediol analyses in the detection ofnon-viable pregnancies. The results of the study of hydatidiform mole (Campbell et al. 1970 ) and of threatened abortion are published in greater detail elsewhere. Although the duration ofpregnancy is remarkably constant in each species, the mechanisms which control the onset of parturition remain poorly understood. Many factors probably influence the contractility of the myometrium during pregnancy; the growing conceptus stretches it; cestrogens stimulate its growth and the development of its contractile mechanism; progesterone may 'block' the conduction of excitatory impulses through it; oxytocin and certain prostaglandins can stimulate its contractility, possibly by different mechanisms.
There is increasing evidence, however, that within the complex regulatory process, the feetus itself makes an important contribution to timing its own delivery and that the onset of labour normally depends on changes in steroid metabolism within the feetoplacental unit which are regulated by the level of activity of the fcetal pituitary adrenal axis.
Uterine Contractility and Maternal (Estrogen Excretion during Pregnancy in
Relation to the Length ofGestation The first evidence we obtained for fetal regulation of uterine contractility was that the level of uterine contractility during pregnancy and the length of gestation were related to the urinary excretion ofcestrogens. Anderson & Turnbull (1968) showed that the human uterus was quiescent up to the 20th week, when some co-ordinated activity began in all patients. Uterine activity increased further in some patients between 32 and 36 weeks and labour always started before term although not usually before 38 weeks. In the remainder, there was relatively little uterine contractility during pregnancy and the onset of labour was delayed past term (Turnbull & Anderson 1968) . These patients were all healthy young primigravidc in whom there was no doubt about the menstrual data or the period of gestation.
Measurement of the urinary excretion of aestriol and cestrone at the 34th week ofpregnancy showed that in patients with a high level of uterine activity and an early onset of labour cestriol excretion was high and cestrone was low.
The lower the urinary cestriol or the higher the cestrone at that stage, the more prolonged was the pregnancy. Pregnanediol excretion was not related to gestational length at the onset of labour (Turnbull et al. 1967 ).
Since the fcetus is known to play a vital part in the intermediary metabolism of cestriol, it was apparent that endocrine activity in the fcetus in some way regulated the level of uterine contractility and the time in pregnancy when labour was to start. Placental function alone seemed unlikely to be critical, since pregnanediol excretion was not related to uterine contractility or the duration of pregnancy. Further studies in human pregnancy suggest that it is feetal adrenal activity, probably under fetal pituitary control, which influences myometrial contractility.
Fawtal Adrenal Cortex in Human Anencephaly in Relation to Length ofGestation This foetal malformation, mainly of the central nervous system, is almost invariably associated with some degree of hypoplasia of the adrenal cortex, probably as a result of pituitary insufficiency. Hydramnios is common and may lead to premature delivery but, in its absence, gestation
